Skip to content

Effect of Exercise on Irisin Levels of Hypothyroid Rats

The Effect of Exercise on Serum Irisin Levels in Hypothyroid Sprague Dawley Rats

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06699069
Enrollment
30
Registered
2024-11-21
Start date
2021-02-20
Completion date
2022-01-30
Last updated
2024-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothyroidism

Keywords

Exercise, Irisin, Hypothyroidism

Brief summary

The aim of study was to evaluate the role of exercise on serum irisin levels in hypothyroid rats.

Detailed description

Contracting skeletal muscle acts as an endocrine organ, capable of secreting hormones called myokines, such as interleukin 1, Interleukin 15 and Irisin. Myokines are important for regulation of glucose and lipid metabolism. Among these, irisin, is an exercise induced polypeptide, secreted mainly by skeletal muscles and adipose tissue. Irisin is also secreted in small amounts from cardiac muscle, pancreas and sebaceous glands. It is cleaved and secreted from fibronectin type III domain-containing protein 5 (FNDC5 gene) and is regulated by the peroxisome proliferator-activated receptor-γ co activator 1-α (PGC1-α) . The most important function of Irisin is thermogenesis, by inducing the browning of white adipose tissue, thereby increasing energy consumption, encouraging weight loss and decreasing dietary insulin resistance. Linking Irisin levels with obesity, its mechanism shows that after exercise there is up regulation of a thermogenin ,an Uncoupling Protein-1 (UCP-1) Thyroid hormone also plays an important role in glucose-lipid metabolism and energy homeostasis. Hypothyroidism, a decrease in thyroid hormone levels, can lead to obesity and metabolic syndrome. It has been found that thyroid hormone is also involved in thermogenesis by inducing browning of white adipose tissue, through thyroid hormone receptors. In hypothyroidism, many metabolic processes in the body are affected such as differentiation in the adipose tissue. Increased thyroid stimulating hormone (TSH) causes adipogenesis by stimulating pre-adipocyte differentiation directly through the receptors in the adipose tissue . Fatty tissue is increased by adipocyte hypertrophy as a consequence of previous adipogenesis, and newly formed adipocyte-8, resulting in clinical obesity. FNDC5 (Fibronectin type III domain-containing protein 5), which is the precursor of irisin, is a protein that is encoded by the FNDC5 gene, is present in many tissues, including the thyroid tissue and therefore effects thyroid hormone. Dysregulation of both Thyroid and Irisin hormones result in metabolic syndrome. The metabolic syndrome is a common metabolic disorder that has been linked to the increasing prevalence of obesity. By regulating thyroid hormone levels, irisin has a powerful impact on metabolism and thermogenesis. The association of irisin with the thyroid hormone in hypothyroidism still remains unknown and is controversial, and requires further confirmatory studies on experimental models. Regular exercise is known to have significant beneficial effects on the metabolic health and this is mediated by skeletal muscle. Contracting skeletal muscle is the source of Irisin. Studies have shown an increase in post exercise Irisin levels

Interventions

OTHERControl or Euthyroid group

Fed on normal standard diet

OTHERHypothyroid group

Experimental hypothyroidism will be induced by administration of propylthiouracil for three weeks in the form of tablets diluted in water

OTHERHypothyroid group received exercise

Rats will be subjected to chronic swimming. The swimming protocol will consist of 8 weeks of low-intensity swimming exercise. The exercise groups will be adapted to a round water tank (70 cm × 70 cm) containing water at 28 ± 2°C for 3 days (10-45 min/day). The rats will then begin swimming, 45 min/day for the first two weeks at 10am and 60 min/day for the last six weeks at 10am

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
6 Weeks to 8 Weeks
Healthy volunteers
No

Inclusion criteria

* Male adult rats weighing approx. 200-250gms * 6 to 8 week old rats

Exclusion criteria

* Female rats will be excluded. * Rats with any obvious pathology * The rats weighing \>200gm

Design outcomes

Primary

MeasureTime frameDescription
Serum Triglycerides (TG)11th weekBy enzymatic method using micro lab analyzer
Serum High Density Lipoproteins (HDL)11th weekDetermined by precipitating method using micro lab analyzer
Serum Low Density Lipoproteins (LDL)11th weekLDL= Total cholesterol-HDL-TG/5
Serum Irisin11th weekEstimation of serum irisin levels (μg/ml) by using enzyme - linked immunosorbent assay (ELISA) using irisin competitive ELISA Kit
Serum Triiodothyronine T311th weekEstimation of serum free triiodothyronine (FT3) levels (ng/ml) by radioimmunoassay
Serum Thyroxine11th weekEstimation of serum free thyroxin (FT4) levels (μg/dl) by radioimmunoassay
Serum Thyroid Stimulating Hormone11th weekBy radioimmunoassay

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026